Outcome Study of the Pipeline Embolization Device With Vantage Technology in Unruptured Aneurysms

Outcome Study of the Pipeline Embolization Device With Vantage Technology in Unruptured Aneurysms

In this project the investigators study the safety and efficacy of the pipeline embolization device with vantage technology in treatment of unruptured brain aneurysms

Inclusion Criteria:

• All patients treated with Pipeline Embolization Device with Vantage Technology (PEDV)
• MRA and/or DSA (or tomographic angiography) available for follow up

Exclusion Criteria:

• Insufficient background data available e.g., to determine size of aneurysm and pipeline device
• PEDV used for causes other than aneurysms, e.g., fistulas and dissection.